Larimar Therapeutics, Inc. (LRMR) Insider Trading

Showing latest transactions and SEC Form 4 filings for LRMR.

11 results.

X Filing Date Trade Date Ticker Company Name Insider Name Title Trade Type Price Qty Owned ΔOwn Value
2026-11-18 16:30:16 2026-11-16 LRMR Larimar Therapeutics, Inc. Clayton Russell Chief Medical Officer P - Purchase $3.01 +3,322 74,765 +5% +$9,999
2026-11-16 17:33:23 2026-11-16 LRMR Larimar Therapeutics, Inc. SHERMAN JEFFREY W Director P - Purchase $3.06 +3,289 8,289 +66% +$10,058
2026-11-12 21:32:19 2026-11-12 LRMR Larimar Therapeutics, Inc. Hamilton Thomas Edward Director P - Purchase $2.67 +70,000 944,231 +8% +$187,082
2026-11-12 18:02:53 2026-11-11 LRMR Larimar Therapeutics, Inc. BEN-MAIMON CAROLE President and CEO, Director P - Purchase $2.77 +18,050 542,104 +3% +$49,953
2026-11-12 18:01:32 2026-11-11 LRMR Larimar Therapeutics, Inc. THOMAS FRANK E Director P - Purchase $2.73 +8,000 15,000 +114% +$21,800
2026-11-12 18:00:54 2026-11-11 LRMR Larimar Therapeutics, Inc. Truitt Joseph Director P - Purchase $2.80 +3,500 6,250 +127% +$9,792
2026-11-12 18:00:18 2026-11-11 LRMR Larimar Therapeutics, Inc. Harlow John B. Jr. President and COO P - Purchase $2.80 +17,800 67,800 +36% +$49,918
2026-11-12 17:56:59 2026-11-11 LRMR Larimar Therapeutics, Inc. Celano Michael Chief Financial Officer P - Purchase $2.71 +18,460 234,245 +9% +$49,992
2026-11-12 17:55:03 2026-11-11 LRMR Larimar Therapeutics, Inc. Shankar Gopi Chief Development Officer P - Purchase $2.71 +5,000 81,443 +7% +$13,549
D 2026-10-01 16:27:13 2026-09-29 LRMR Larimar Therapeutics, Inc. Harlow John B. Jr. President and COO A $0.00 +850,000 50,000 0% $0